Skip to main content

Gain Therapeutics, Inc.

GANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001819411

No open-market purchases or sales by Gain Therapeutics, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; Greenlight Capital is the only superinvestor holding it.

13F holders, Q1 2026

Institutional positions in Gain Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
42
−5 vs. Q4 2025
Shares held
8.19M
+706.6K (+9.4%) vs. Q4 2025
Total value
$15.8M
−$8.27M (−34.3%) vs. Q4 2025
New holders
10
9 more added
Sold out
15
10 more reduced

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 42 institutions
Q1 2021: 12 institutionsQ2 2021: 14 institutionsQ3 2021: 14 institutionsQ4 2021: 19 institutionsQ1 2022: 16 institutionsQ2 2022: 16 institutionsQ3 2022: 23 institutionsQ4 2022: 21 institutionsQ1 2023: 22 institutionsQ2 2023: 24 institutionsQ3 2023: 24 institutionsQ4 2023: 24 institutionsQ1 2024: 26 institutionsQ2 2024: 28 institutionsQ3 2024: 19 institutionsQ4 2024: 25 institutionsQ1 2025: 33 institutionsQ2 2025: 35 institutionsQ3 2025: 38 institutionsQ4 2025: 48 institutionsQ1 2026: 42 institutionsQ2 2026: 50 institutions
Value heldQ1 2026: $15.8M
Q1 2021: $15.0MQ2 2021: $8.95MQ3 2021: $6.65MQ4 2021: $5.71MQ1 2022: $4.75MQ2 2022: $3.87MQ3 2022: $3.95MQ4 2022: $3.78MQ1 2023: $5.54MQ2 2023: $5.68MQ3 2023: $4.95MQ4 2023: $5.05MQ1 2024: $7.04MQ2 2024: $3.89MQ3 2024: $2.40MQ4 2024: $3.94MQ1 2025: $5.07MQ2 2025: $6.49MQ3 2025: $7.70MQ4 2025: $25.9MQ1 2026: $15.8MQ2 2026: $17.4M
Institutions holding GANX and their total value by quarter
QuarterHoldersValue
Q2 202650$17.4M
Q1 202642$15.8M
Q4 202548$25.9M
Q3 202538$7.70M
Q2 202535$6.49M
Q1 202533$5.07M
Q4 202425$3.94M
Q3 202419$2.40M
Q2 202428$3.89M
Q1 202426$7.04M
Q4 202324$5.05M
Q3 202324$4.95M
Q2 202324$5.68M
Q1 202322$5.54M
Q4 202221$3.78M
Q3 202223$3.95M
Q2 202216$3.87M
Q1 202216$4.75M
Q4 202119$5.71M
Q3 202114$6.65M
Q2 202114$8.95M
Q1 202112$15.0M

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Gain Therapeutics, Inc.; share changes are against Q4 2025.

Institutions holding GANX in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Marshall Wace, LLP1,769,788$3.43M0.00%+107,495+6.5%Added
Potomac Capital Management, Inc.1,008,600$1.96M1.71%−1,400−0.1%Reduced
Jones Financial Companies LLLP631,615$1.16M0.00%−70,598−10.1%Reduced
Cambridge Investment Research Advisors, Inc.568,645$1.10M0.00%00.0%Unchanged
DME Capital Management, LPSuperinvestorGreenlight Capital566,130$1.10M0.03%00.0%Unchanged
Geode Capital Management, LLC447,342$868.5K0.00%+49,400+12.4%Added
Susquehanna International Group, LLP431,267$836.7K0.00%−253,082−37.0%Reduced
Vanguard Capital Management LLC399,886$775.8K0.00%+399,886New
Gsa Capital Partners LLP312,467$606.0K0.04%+291,995+1,426.3%Added
Vanguard Fiduciary Trust Co229,979$446.2K0.00%+229,979New
BlackRock, Inc.225,046$436.6K0.00%+15,467+7.4%Added
UBS Group AG220,489$427.7K0.00%+139,368+171.8%Added
Jane Street Group, LLC216,883$420.8K0.00%−25,445−10.5%Reduced
Cresset Asset Management, LLC160,000$310.4K0.00%00.0%Unchanged
State Street Corp157,537$305.6K0.00%00.0%Unchanged
Morgan Stanley139,652$270.9K0.00%−7,939−5.4%Reduced
Stratos Wealth Partners, LTD.131,621$255.3K0.00%+131,621New
Northern Trust Corp113,997$221.2K0.00%+11,996+11.8%Added
LPL Financial LLC104,251$202.2K0.00%−2,299−2.2%Reduced
Prelude Capital Management, LLC35,820$69.5K0.01%00.0%Unchanged
Bridgeway Capital Management, LLC30,004$58.2K0.00%00.0%Unchanged
Commonwealth Equity Services, LLC29,703$57.6K0.00%+17,018+134.2%Added
Apollon Wealth Management, LLC26,500$51.4K0.00%+6,675+33.7%Added
Citadel Advisors LLC24,900$48.3K0.00%+24,900New
Schonfeld Strategic Advisors LLC24,500$47.5K0.00%+24,500New
Oliver Luxxe Assets LLC20,250$39.3K0.01%00.0%Unchanged
Vanguard Global Advisers, LLC18,376$35.6K0.00%+18,376New
Wealthspire Advisors, LLC16,900$32.8K0.00%00.0%Unchanged
Benedict Financial Advisors Inc15,500$30.1K0.01%−22,500−59.2%Reduced
Sandhill Capital Partners LLC15,400$29.9K0.00%00.0%Unchanged
Millington Financial Advisors, LLC15,000$29.3K0.01%+15,000New
Wealth Enhancement Advisory Services, LLC15,556$28.8K0.00%00.0%Unchanged
Simplex Trading, LLC13,439$26.1K0.00%−34,507−72.0%Reduced
Kestra Advisory Services, LLC12,000$23.3K0.00%00.0%Unchanged
Wells Fargo & Company11,050$21.4K0.00%+8,400+317.0%Added
Virtu Financial LLC10,685$21.0K0.00%+10,685New
GWM Advisors LLC10,600$20.6K0.00%00.0%Unchanged
Group One Trading, L.P.6,404$12.4K0.00%−47,755−88.2%Reduced
Tower Research Capital LLC (TRC)5,506$10.7K0.00%−1,353−19.7%Reduced
JPMorgan Chase & Co1,700$3.06K0.00%+1,700New
Larson Financial Group LLC10$190.00%00.0%Unchanged
Citigroup Inc1$20.00%+1New
Colony Group, LLC0$00.00%−77,855−100.0%Sold out
HRT Financial LP0$00.00%−55,679−100.0%Sold out
Omers Administration Corp0$00.00%−37,300−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−32,494−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−32,480−100.0%Sold out
Lighthouse Investment Partners, LLC0$00.00%−23,040−100.0%Sold out
Renaissance Technologies LLC0$00.00%−17,400−100.0%Sold out
Engineers Gate Manager LP0$00.00%−14,617−100.0%Sold out
Millennium Management LLC0$00.00%−14,002−100.0%Sold out
Sprott Inc.0$00.00%−12,000−100.0%Sold out
MAI Capital Management0$00.00%−4,410−100.0%Sold out
Bank of America Corp0$00.00%−3,908−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−2,381−100.0%Sold out
FNY Investment Advisers, LLC0$00.00%−2,000−100.0%Sold out
State of Wyoming0$00.00%−1,438−100.0%Sold out
Vanguard Group Inc––––Not filed